Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Here's Why You Should Retain McKesson (MCK) Stock Right Now
02:11pm, Tuesday, 05'th Jul 2022 Zacks Investment Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
3 Reasons to Add Masimo (MASI) Stock to Your Portfolio Now
01:06pm, Tuesday, 28'th Jun 2022
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Is Masimo (MASI) a Solid Growth Stock? 3 Reasons to Think " Yes "
02:18pm, Tuesday, 31'st May 2022
Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Masimo's (MASI) PVi Favored by New Study for Pediatric Patients
12:18pm, Wednesday, 25'th May 2022
Masimo's (MASI) PVi is expected to take better treatment decisions for pediatric patients with signs of obstructive respiratory disease in the EDs.
Can Masimo (MASI) Run Higher on Rising Earnings Estimates?
01:32pm, Friday, 20'th May 2022
Masimo (MASI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Masimo CEO talks acquisition of Sound United
07:43pm, Monday, 16'th May 2022
CNBC's Jim Cramer spoke with Masimo CEO Joe Kiani on Monday's episode of "Mad Money."
Wall Street Analysts Think Masimo (MASI) Could Surge 135%: Read This Before Placing a Bet
11:17am, Monday, 16'th May 2022
The mean of analysts' price targets for Masimo (MASI) points to a 134.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Masimo Closes a Questionable Acquisition
12:25pm, Sunday, 15'th May 2022
Masimo ( MASI , Financial) is a relatively unknown mid-cap medical technology player which focuses on the development, manufacturing and marketing of non-invasive patient monitoring technologies. Foun
Looking for a Growth Stock? 3 Reasons Why Masimo (MASI) is a Solid Choice
03:03pm, Monday, 09'th May 2022
Masimo (MASI) possesses solid growth attributes, which could help it handily outperform the market.
Masimo (MASI) Upgraded to Buy: Here's What You Should Know
01:33pm, Friday, 06'th May 2022
Masimo (MASI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues
11:34am, Wednesday, 04'th May 2022
Masimo Corp's (NASDAQ: MASI) Q1 revenue increased 1.7% Y/Y (+3.2% on a constant currency basis) to $304.2 million, beating the consensus of $303.83 million. Excluding handheld and fingertip pulse o
Masimo (MASI) Q1 Earnings and Revenues Surpass Estimates
08:19pm, Tuesday, 03'rd May 2022
Masimo (MASI) delivered earnings and revenue surprises of 1.09% and 3.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Masimo Corporation (MASI) CEO Joe Kiani on Q1 2022 Results - Earnings Call Transcript
07:00pm, Tuesday, 03'rd May 2022
Masimo Corporation (NASDAQ:MASI ) Q1 2022 Results Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Eli Kammerman - Vice President-Business Development and Investor Relations Joe Ki
Masimo Corp. stock drops more than 10% after mixed Q1 earnings
05:01pm, Tuesday, 03'rd May 2022
Masimo Corp. MASI, -0.99% stock fell more than 10% in the extended session Tuesday after the medical technology company reported mixed first-quarter earnings, saying that it faced "unexpected" supply-
Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales
01:33pm, Thursday, 31'st Mar 2022
Masimo Corp (NASDAQ: MASI) expects Q1 FY22 product revenue of $285 million - $315 million, lower than expected. Shortages of critical components and other supply chain issues, including freight carr
